Sponsor Pipeline

Highlightll Pharmaceutical (USA) LLC Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
1
Active Trials
1
Recruiting
1
Disease Areas
Active Trials by Phase
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1
NCT06997484 First-in-Human Single and Multiple Dose of HL-400 Parkinson Disease Recruiting
Disease Areas
Parkinson's Disease (1)
Get alerts when Highlightll Pharmaceutical (USA) LLC's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free